Mankind Pharma Ltd. aims to become a debt-free company within the next three years, Vice Chairman and Managing Director ...

Brand-heavy companies such as Mankind Pharma, Sun Pharma, Torrent Pharmaceuticals and Eris Lifesciences are expected to ...

Mankind Pharma's shares surged by 6% after reporting a 29% rise in Q2 profits, reaching ₹658.88 crore. The company attributed ...

In a stock exchange filing on Tuesday, the company reported a 30% increase in consolidated net profit to ₹653 crore in the ...

Mankind Pharma, one of India’s largest pharmaceutical players, witnessed its shares surge by 6 per cent to a peak of Rs 2,882 ...

Shares of Mankind Pharma surged more than 6 per cent to hit new 52-week highs on Wednesday after the company announced a ...

Mankind Pharma witnessed a 29% surge in consolidated net profit, reaching Rs 658.88 crore in the second quarter, ending ...

Domestic revenue reached ₹2,796 Crore, an 11% YoY increase, while exports saw significant growth, jumping 57% to ₹281 Crore.

Mankind Pharma has recorded a 29 per cent increase in consolidated net profit, reaching Rs 658.88 crore for the second ...

Mankind Pharma's net profit surged 29% to Rs 659 cr in Q2 FY25, driven by volume recovery and strong EBITDA margins. Revenue ...

Mankind Pharma reported a 29% year-on-year increase in its consolidated net profits for the second quarter of this fiscal, reaching ₹658.88 crore, up from ₹473 crore in the same period last year. The ...